Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT

John B Christoforidis, Michelle M. Williams, Shankaran Kothandaraman, Krishan Kumar, Frank J. Epitropoulos, Michael V. Knopp

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Purpose: To determine the anatomic characteristics and pharmacokinetic properties of intravitreally-placed aflibercept in a rabbit model. Materials and methods: Four Dutch-belted rabbits underwent intravitreal injection with I-124-aflibercept. Serial imaging with PET/CT imaging was performed on days 0, 2, 5, 7, 14, 21, 28 and 35. Measured radioactivity emission in becquerels/mL was used to calculate the half-lives for aflibercept. Results: I-124 aflibercept was confined within the vitreous cavity for the duration of the study. I-124 aflibercept could be detected in the vitreous cavity until day 28 and the average retention time with standard error after correction for radioactive decay was 4.58±0.07 days. Conclusions: I-124 aflibercept was only visible in the vitreous cavity by PET/CT imaging following intravitreal injection. The retention properties were found to be comparable to those measured by other reported methods.

Original languageEnglish (US)
Pages (from-to)1171-1174
Number of pages4
JournalCurrent Eye Research
Volume37
Issue number12
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Pharmacokinetics
Rabbits
Intravitreal Injections
Radioactivity
aflibercept

Keywords

  • Aflibercept
  • Iodine-124
  • Pharmacokinetics
  • Positron emission tomography
  • Radiolabeling

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT. / Christoforidis, John B; Williams, Michelle M.; Kothandaraman, Shankaran; Kumar, Krishan; Epitropoulos, Frank J.; Knopp, Michael V.

In: Current Eye Research, Vol. 37, No. 12, 12.2012, p. 1171-1174.

Research output: Contribution to journalArticle

Christoforidis, JB, Williams, MM, Kothandaraman, S, Kumar, K, Epitropoulos, FJ & Knopp, MV 2012, 'Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT', Current Eye Research, vol. 37, no. 12, pp. 1171-1174. https://doi.org/10.3109/02713683.2012.727521
Christoforidis, John B ; Williams, Michelle M. ; Kothandaraman, Shankaran ; Kumar, Krishan ; Epitropoulos, Frank J. ; Knopp, Michael V. / Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT. In: Current Eye Research. 2012 ; Vol. 37, No. 12. pp. 1171-1174.
@article{b371689d65d14af5a95d1dfcb8e09c46,
title = "Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT",
abstract = "Purpose: To determine the anatomic characteristics and pharmacokinetic properties of intravitreally-placed aflibercept in a rabbit model. Materials and methods: Four Dutch-belted rabbits underwent intravitreal injection with I-124-aflibercept. Serial imaging with PET/CT imaging was performed on days 0, 2, 5, 7, 14, 21, 28 and 35. Measured radioactivity emission in becquerels/mL was used to calculate the half-lives for aflibercept. Results: I-124 aflibercept was confined within the vitreous cavity for the duration of the study. I-124 aflibercept could be detected in the vitreous cavity until day 28 and the average retention time with standard error after correction for radioactive decay was 4.58±0.07 days. Conclusions: I-124 aflibercept was only visible in the vitreous cavity by PET/CT imaging following intravitreal injection. The retention properties were found to be comparable to those measured by other reported methods.",
keywords = "Aflibercept, Iodine-124, Pharmacokinetics, Positron emission tomography, Radiolabeling",
author = "Christoforidis, {John B} and Williams, {Michelle M.} and Shankaran Kothandaraman and Krishan Kumar and Epitropoulos, {Frank J.} and Knopp, {Michael V.}",
year = "2012",
month = "12",
doi = "10.3109/02713683.2012.727521",
language = "English (US)",
volume = "37",
pages = "1171--1174",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT

AU - Christoforidis, John B

AU - Williams, Michelle M.

AU - Kothandaraman, Shankaran

AU - Kumar, Krishan

AU - Epitropoulos, Frank J.

AU - Knopp, Michael V.

PY - 2012/12

Y1 - 2012/12

N2 - Purpose: To determine the anatomic characteristics and pharmacokinetic properties of intravitreally-placed aflibercept in a rabbit model. Materials and methods: Four Dutch-belted rabbits underwent intravitreal injection with I-124-aflibercept. Serial imaging with PET/CT imaging was performed on days 0, 2, 5, 7, 14, 21, 28 and 35. Measured radioactivity emission in becquerels/mL was used to calculate the half-lives for aflibercept. Results: I-124 aflibercept was confined within the vitreous cavity for the duration of the study. I-124 aflibercept could be detected in the vitreous cavity until day 28 and the average retention time with standard error after correction for radioactive decay was 4.58±0.07 days. Conclusions: I-124 aflibercept was only visible in the vitreous cavity by PET/CT imaging following intravitreal injection. The retention properties were found to be comparable to those measured by other reported methods.

AB - Purpose: To determine the anatomic characteristics and pharmacokinetic properties of intravitreally-placed aflibercept in a rabbit model. Materials and methods: Four Dutch-belted rabbits underwent intravitreal injection with I-124-aflibercept. Serial imaging with PET/CT imaging was performed on days 0, 2, 5, 7, 14, 21, 28 and 35. Measured radioactivity emission in becquerels/mL was used to calculate the half-lives for aflibercept. Results: I-124 aflibercept was confined within the vitreous cavity for the duration of the study. I-124 aflibercept could be detected in the vitreous cavity until day 28 and the average retention time with standard error after correction for radioactive decay was 4.58±0.07 days. Conclusions: I-124 aflibercept was only visible in the vitreous cavity by PET/CT imaging following intravitreal injection. The retention properties were found to be comparable to those measured by other reported methods.

KW - Aflibercept

KW - Iodine-124

KW - Pharmacokinetics

KW - Positron emission tomography

KW - Radiolabeling

UR - http://www.scopus.com/inward/record.url?scp=84870256403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870256403&partnerID=8YFLogxK

U2 - 10.3109/02713683.2012.727521

DO - 10.3109/02713683.2012.727521

M3 - Article

C2 - 22991959

AN - SCOPUS:84870256403

VL - 37

SP - 1171

EP - 1174

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 12

ER -